Lifeline Scientific Inc.

Medtech Investing Secondary Buyers Offer Exit for BSX, Others Saints Capital’s decision to pay $100 million for 54 companies from Boston Scientific Corp .’s corporate venture profile is an obvious ou

A look at medical device and in vitro diagnostics/research financing, M&A, and alliance activity January–March 2008 In this issue, we present a review of medical device and in vitro diagnostics/rese